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ABSTRACT We analyze the encounter of a peptide substrate with the native HIV-1 protease, the mechanism of substrate in-
corporation in the binding cleft, and the dissociation of products after substrate hydrolysis. To account for the substrate, we extend
a coarse-grained model force ﬁeld, which we previously developed to study the ﬂap opening dynamics of HIV-1 protease on a
microsecond timescale. Molecular and Langevin dynamics simulations show that the ﬂaps need to open for the peptide to bind
and that the protease interaction with the substrate inﬂuences the ﬂap opening frequency and interval. On the other hand,
release of the products does not require ﬂap opening because they can slide out from the binding cleft to the sides of the
enzyme. Our data show that in the protease-substrate complex the highest ﬂuctuations correspond to the 17- and 39-turns and
the substrate motion is anticorrelated with the 39-turn. Moreover, the active site residues and the ﬂap tips move in phase with
the peptide. We suggest some mechanistic principles for how the ﬂexibility of the protein may be involved in ligand binding and
release.
INTRODUCTION
Human immunodeﬁciency virus (HIV) type 1 protease (HIV-1
PR) cleaves the viral poly-proteins during the replication of
the HIV virus. Because this process is indispensable for the
life cycle of the virus, inhibitors of HIV-1 PR are widely
used in the treatment of HIV/AIDS (1–3). However, due to
the rapid development of drug resistance of the virus and side
effects encountered upon treatment, new inhibitors of HIV-1
PR are constantly needed.
HIV-1 PR is a 198-residue homodimer whose active site is
covered by two ﬂexible b-hairpins, called ﬂaps, controlling
the entry of the polypeptide substrate (see Fig. 1). The ﬂaps
are believed to sterically restrict access of a polypeptide to
the active site. The initial stage of the reaction involves the
encounter of a substrate with the protease followed by its
entry and proper incorporation in the binding site. After the
substrate is cleaved, the products leave the binding site.
Because a deeper understanding of the events associated
with the ligand binding and dissociation from the active site
of HIV-1 PR is important for the design of more potent and
selective inhibitors, both experimental and theoretical stud-
ies aim at elucidating the internal dynamics of this enzyme.
Crystal structures of ligand bound HIV-1 proteases show
that the ﬂaps are in their closed conﬁguration, tightly cover
the binding site, and make hydrogen bonds with the ligand.
The ﬂaps in the free HIV-1 PR are more loosely packed and
less compact (Fig. 2, red ribbon) but still relatively closed
over the active site. An x-ray structure of a mutant in which
the ﬂap tips separate as far as 12 A˚ was reported (4), but it
was shown in recent molecular dynamics (MD) simulations
that this widening of the ﬂaps might be induced by crystal
packing (5). Packing effects might, on the other hand, pre-
clude crystallographic observation of the conﬁguration of the
protease with wider open ﬂaps.
The dynamical picture from NMR experiments for the free
HIV-1 PR reveals substantial conformational alterations in
the ﬂap region (6). The ﬂap movements occur on a micro- to
millisecond timescale with faster motions on a sub-nanosec-
ond timescale. In the inhibitor-bound protease, ﬂexibility of
the ﬂaps is suppressed (7,8).
The mobility of the ﬂaps in the free protease has been
studied by all-atom MD. With an external force, the ﬂaps
conﬁguration changed from a closed to a semi-open form (9).
Based on a 10-ns MD, a curling mechanism was proposed to
be involved in ﬂap opening but the short timescale of the
simulations precluded reclosing (10). In a simulation of an
unbound V82F/I84V HIV-1 PR mutant, only a slight ﬂap
separation was observed (11). More substantial ﬂap opening
was achieved in accelerated MD (12). Recently, a 42-ns un-
constrained all-atomMD displayed both opening and reclosing
of the ﬂaps (13). MD with implicit solvation in internal tor-
sion angle space at various temperatures was also performed
and separation of the ﬂaps was observed (14).
Analyses of the substrate ﬂuctuations in the active site of
the protease were also carried out with all-atom MD (15,16).
These studies show that the substrate motion is correlated
with the motion of residues 24–30 that form the cleavage site
and residues 45–55, which form the ﬂaps and especially with
the ﬂap tips (residues 48–51). The conformational ﬂexibility
of the substrate in the binding cleft was found to be crucial
for the reaction. The connection between ﬂap motion and the
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binding of a fullerene-based inhibitor was investigated with
all-atom MD including the free energy proﬁle obtained by
thermodynamic integration (17). Other studies showed that
the ﬂaps close upon incorporation of the ligand in the bind-
ing cleft and provided a detailed all-atomic description of the
closure (18,19). To the best of our knowledge, there are no
studies that simulate the dynamics of product release after
cleavage. An all-atomic quantum-mechanical molecular dy-
namics simulation of the peptide bond breakage was per-
formed but, due to the picosecond timescale, the dissociation
of the peptide bond only up to 3.6 A˚ was observed (20) and
the cleaved peptide did not leave the binding pocket.
In this work, we aim to study the entire mechanism of the
reaction dynamics, i.e., the diffusion of the substrate toward
the enzyme, its proper entry, and accommodation in the
binding site, which involves both ﬂap opening and reclosing
events, and the mobility of the substrate after the peptide
bond cleavage. Because these events occur on a very long
timescale, we performed molecular dynamics simulations
with a reduced model, which was developed in our recent
studies (21–23). Thanks to the extreme coarse-graining (i.e.,
one interacting center per amino acid), our model allows sim-
ulations on the timescale of tens of microseconds. Never-
theless, the model is sophisticated enough to reproduce high
mobility of the ﬂap region, i.e., the full ﬂap opening dy-
namics. We previously reported (22) a large number of sim-
ulations in different statistical ensembles and an extensive
analysis of the ﬂap opening dynamics, thermodynamics, and
kinetics of the unbound HIV-1 PR. Results are in agreement
with the available experimental data and can be considered a
validation of the model. Recently, we have also reported a
combined coarse-grained (CG) and MD simulation where
the approach of XK-263 inhibitor was studied with CG MD
and the docking was reﬁned with an all-atom MD simulation
(24). Conversely, in this work the whole process is studied
with CG MD. We parameterized a speciﬁc HIV-1 PR-
substrate force ﬁeld (FF) to obtain accurate structures of the
complex. The results allow us to analyze not only the
docking and accommodation of the substrate in the active
site, but also the structural and dynamical changes induced
by the substrate on HIV-1 PR upon binding. We subse-
quently simulate the release of the products after cleavage
by ad hoc modiﬁcation of the FF of the substrate to mimic
the bond breakage. We study various binding paths through
which the peptide approaches the enzyme.
METHODS
In our model, an amino acid is represented by a single bead placed on the
Ca. HIV-1 PR in a coarse-grained representation is shown in Fig. 1. Such
description is analogous to the elastic or Gaussian network models or Go-
type models (25–28). However, the latter approaches are not ﬂexible enough
to explore appropriately the nonnative conﬁgurations, which are far from
equilibrium, due to an extremely simpliﬁed functional form choice and
parameterization. Conversely, our force ﬁeld resembles the all-atom
molecular mechanics force ﬁelds and is based on a class of one-bead FF
models (29–31). The effective potential energy U is the sum of three bonded
terms (pseudo-bond, pseudo-bond angle, pseudo-dihedral) and three non-
bonded terms:
U ¼ Ub1Uu1Ua1Ulocnb 1Unonlocnb 1Unonlocel : (1)
The parameterization is based on the statistical analysis of a set of
crystallographic structures (21). Particular care is devoted to the amino acid-
dependent term Uu, represented as a quartic double-well potential, which is
responsible for the conformational changes involved in the ﬂap opening
(21). The correct hydrogen-bond topology is ensured by retaining a local
bias in the termUlocnb , based on the native structure of the protease (PDB code
1HHP). This bias is applied, based on the spatial distance, to residues that are
within 8 A˚ apart. The nonlocal nonbonded term, Unonlocnb , is a general one
and is not dependent on initial structure. The local interactions contain
electrostatics implicitly but for the nonlocal nonbonded interactions, we
introduce the Coulombic term, which makes the interaction between charged
amino acids stronger. The details of the force ﬁeld and parameterization can
FIGURE 2 (Left) Structure of free HIV-1 PR (1HHP)
before docking (red), aligned to a representative structure
of the complex (blue and green) extracted from an NVT
simulation of HIV-1 PR with a docked substrate. (Right)
Crystallographic structure of the complex (PDB entry
1F7A) for comparison. The root mean-squared deviation
of the complex from the 1F7A conﬁguration during the
simulation ranges from 1.5 to 1.7 A˚.
FIGURE 1 Heavy atom and one-bead coarse-grained representation of
HIV-1 PR homodimer in the complex with a peptide substrate Lys-Ala-Arg-
Val-Leu–Ala-Glu-Ala-Met (PDB entry code 1F7A (32)). The Ca nuclei of
monomers and the substrate are denoted in blue, red, and green, respectively.
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be found in Tozzini et al. (22). For the electrostatic interactions,Unonlocel , we
used integer charges for Asp, Glu, Lys, and Arg according to their
protonation in solution at pH 7 and a distance-dependent dielectric e¼ 4r to
account for the screening. We previously showed that this setup is an
excellent compromise between simplicity-reduced computational cost and
accuracy. The structures of intermediate steps of ﬂap opening compare very
well with the available x-ray structure (4). Additionally, the model allows for
complete ﬂap opening whose kinetics and thermodynamics are in agreement
with experimental data (22).
As a substrate, we used the nine-residue peptide Lys-Ala-Arg-Val-Leu-
Ala-Glu-Ala-Met. The FF for the substrate and the substrate-HIV-1 PR
interaction was extended following the same procedure as described in
Tozzini et al. (22). 1F7A (32) PDB entry was chosen as the reference
structure for the substrate-protease interaction part of the FF. To check the
accuracy of the complex structure, a simulation at room temperature starting
from the 1HHP (semi-open) structure with manually docked substrate was
performed. Its analysis shows that the substrate correctly accommodates in
the active site and the ﬂaps close more tightly as an effect of the interaction
with the substrate, acquiring a conﬁguration that is very similar to the
experimental substrate-protease complex (see Fig. 2). Consequently, in the
present work we do not need to use an all-atom simulation for the last phases
of binding and for the reﬁnement of the complex structure as we did in
our previous work (24), where a more generic CG FF was used for the
ligand-protease interaction.
For the intermolecular substrate-HIV-1 PR interactions, we used a phe-
nomenological scaling factor R, with respect to the intramolecular interac-
tions, that accounts for the possible range of the solvation effects. Different
values ranging from 0.2 to 1 were considered. R ’ 1 produces a faster
binding kinetics, while R’ 0.2 reproduces the range of the binding enthalpy
of the substrate which we estimated to be;5–6 kcal/mole from the values of
equilibrium association constants of the order of 104 M1 (33) and catalytic
efﬁciency (kcat/Km) in the millimolar range for short peptides (34).
To limit the conformational phase space sampled in the simulation, the
FF for the substrate was harmonically constrained to the extended confor-
mation that it assumes in the active site. We used a single well potential for
Uu instead of the usual double well one, because the inﬂuence of the sub-
strate conformational dynamics on the binding is beyond the scope of the
present work.
The FF for the cleaved substrate is simply obtained by deleting the one
Ca-Ca pseudo-bond, the two pseudo-bond angle, and three pseudo-dihedral
terms involved in the cleaved peptide bond between Leu and Ala. Addi-
tionally, the local contacts between the Leu, Ala, and the substrate were
eliminated, since the geometry-speciﬁc backbone hydrogen bonds that these
residues make with the enzyme are no longer possible when the peptide
bond is broken. However, these residues can still interact with HIV-1 PR
with hydrophobic and electrostatic nonbonded interactions. This FF for the
HIV-1 PR-substrate complex is a natural extension of the HIV-1 PR one,
which we previously parameterized, and is fully consistent with it, thus the
results can be directly compared with those in Tozzini et al. (22).
We performed multiple MD simulations in the NVT ensemble using the
Berendsen thermostat (35), as well as Langevin Dynamics (36) (LD), which
was implemented into DL_POLY package (37). Time step was set to 0.02
ps. Based on the results of our previous work (22), where we addressed the
dependence of ﬂap opening dynamics on the viscosity of the solvent either in
Langevin or Brownian dynamics, the collision frequency parameter in LD
was set to 2 ps1. A value of 1 ps1 leads to faster binding of the substrate
and a value of 5 ps1 results in higher damping and slows the binding event.
One has to emphasize that the binding times are not necessarily realistic and
what we aim to address in this work are the binding pathways not the
timescales. For analysis of the internal ﬂuctuations, we performed an
independent ﬁt of each trajectory frame on the same reference to eliminate
the contribution from the translation and rotation of the protease. To analyze
the principal directions of motions we applied Principal Components Anal-
ysis (38) of the GROMACS package (39) and visualized it with Essential
Dynamics Software (40) under VMD (41). Table 1 reports some of the
simulation parameters, others are as in Tozzini et al. (22). Results cor-
responding to these simulations are reported in the indicated ﬁgures in the
next sections.
RESULTS AND DISCUSSION
In this section, we report the analyses of the encounter of the
substrate with the protease, the ﬂuctuations of the complex,
and the products’ release after cleavage.
Substrate binding and product release pathways
We performed several simulations of the substrate encounter
with the protease and its accommodation in the binding cleft. In
the startingconﬁguration thepositionof the substratewas chosen
;80–100 A˚ away from the protease from its various sides.
A sample LD simulation (Table 1, No. 3) of the substrate
encounter and accommodation in the active site is presented
in Fig. 3. The corresponding center-of-mass distance be-
tween the protease and the substrate, and the ﬂap tip distance
are shown in Fig. 4. After initial diffusion (up to 20 ns, Fig.
3 A) toward the enzyme, the substrate waits in proximity to
the binding site (Fig. 3 B). Later, between 60 and 100 ns (Fig.
3 C), the ﬂaps open many times but the substrate is not
correctly positioned to enter the binding site. Next, the
substrate changes its position and moves to the other side of
the binding cleft (Fig. 3 D). Flaps open again for a longer
period of time and the substrate enters the binding cleft at
;215 ns (Fig. 3 E), which results in closure of one ﬂap. This
is visible in smaller ﬂuctuations of the ﬂap tip distance after
215 ns (Fig. 4). When the substrate properly accommodates
itself in the cleft the other ﬂap closes (Fig. 3 F) at ;250 ns.
Subsequently, the ﬂuctuations of the ﬂap tips decrease in
comparison with those in the beginning of the simulation
TABLE 1 Details of simulations, which were used to prepare
ﬁgures in Results
No. Thermostat R Simulation length Figures
Native HIV-1 PR
1 NVT 1 10 ms Figs. 7 and 8 (left)
HIV-1 PR:substrate complex
2 NVT 1 600 ns Figs. 2, 7, 8 (right) and 9
HIV-1 PR:substrate docking
3 LD 1 400 ns (side)* Figs. 3, 4, and 5 B
4 LD 1 400 ns (ﬂaps)y Fig. 5 A
5 LD 1 1ms (termini)z Fig. 5 C
6 LD 0.2 1.2 ms Fig. 6 A
7 LD 0.2 400 ns Fig. 6 B
HIV-1 PR:cleaved substrate
8 LD 0.2 300 ns Figs. 3 and 4 (continuation of
simulation No. 3)
In some ﬁgures, for the sake of comparison, only parts of the trajectories
were used. The temperature was set to 300 K in every simulation.
*Starting position of the substrate as 80–100 A˚ from the side of the
protease.
yStarting position from the top above the ﬂaps.
zStarting position from the side of the termini.
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when the substrate was outside the protease. Both the open-
ing of the ﬂaps and correct positioning of substrate must oc-
cur for the substrate incorporation in the cleft. The substrate
may wander around the protease from one side of the active
site to the other, exploring its surface and waiting for the
ﬂaps to open. In addition, the proximity of the substrate to
the ﬂaps inﬂuences their mobility, stabilizing slightly the open
conformation with respect to the unbound protease case.
The asymmetric closure of ﬂaps may arise from the fact
that it was found in mutation experiments that substrate
hydrogen bonding at the Gly49-Ile50 peptide bond in only
one ﬂap is sufﬁcient for normal reaction to take place
(42).
At 400 ns, we performed the Leu5-Ala6 bond breakage and
continued the simulation for another 300 ns. The products
left the active site on the nanosecond timescale and did not
require ﬂap opening for their release from the binding cleft
(Fig. 3, G and H). Release was asymmetric, i.e., it took
longer for one side of the substrate to leave the binding cleft
than for the other. Similar to the substrate in some simu-
lations, the products remain in the proximity of the HIV-1
PR surface (Fig. 3 H) at;20 A˚ away from its center of mass
before deﬁnitely diffusing away at;550 ns (Fig. 3 I; see also
Fig. 4). Immediately after the cleavage and release, the
normal dynamics of HIV-1 PR is recovered, with average
opening and closing intervals that are typical of the unbound
protease (22). In addition, the ﬂuctuations of the ﬂap tip dis-
tances are higher when the substrate leaves its binding site
(compare the inter-tip distance in the range 200–400 ns after
the substrate binds and after 400 ns when the products had
left the enzyme in Fig. 4). The graph also shows that the ﬂaps
can close more tightly when the substrate is bound (compare
the shift in the minimum value of the inter-tip distance before
and after the substrate release).
In the simulations after the cleavage, the new termini of
the products were kept either charged or neutral because their
protonation states during the release process are not known.
We found that the product termini titration states do not
affect their release from the enzyme. Their protonation state
affects only the simulation time, which is required for their
diffusion from the surface of the enzyme. If the termini are
charged, the products more easily ﬁnd a position with respect
to the enzyme with favorable electrostatic interactions. Because
we have two more charged residues in comparison with the
neutral termini, it might take longer for these electrostatic
interactions to allow the substrate to diffuse.
FIGURE 3 Snapshots from a substrate docking,
cleavage, and release simulation. Protease monomers
are denoted as Ca trace in light and dark shading, and
the substrate is represented as spheres. (A) Initial
diffusion toward the protease (20 ns). (B) Substrate
outside the protease waiting for the ﬂaps to open. (C)
Open ﬂaps (80 ns) but the substrate is not correctly
positioned to enter. (D) Substrate moves to the other
side of the binding cleft (120 ns) and ﬂaps open again
(140 ns). (E) The substrate enters the binding site
(215 ns) and one ﬂap closes over the substrate. (F)
Proper accommodation of substrate with both ﬂaps
closed (250 ns). (G) The breakage of the substrate after
induced at 400 ns cleavage. (H) Release of the products
from the binding cleft. (I) Diffusion of products away
from the protease.
FIGURE 4 Substrate docking and product release simulation with labels
corresponding to the frames in Fig. 3. (Upper plot) Distance between the
centers of mass of the protease and the substrate or two substrate parts after
cleavage (products). Two distance scales are provided divided by black
vertical line. (Lower plot) The corresponding ﬂap tip (Ile50-Ile150) distance.
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In the simulations of substrate association, the initial po-
sition of the substrate and type of the dynamics was subject
to change. However, it did not affect the general binding
pathway picture and incorporation scheme of the substrate.
Fig. 5 shows the density of the substrate from simulations
with different starting substrate positions with respect to
HIV-1 PR, conﬁrming that the substrate explores the surface
of the enzyme.
Even though the initial trajectory of the substrate depends
on its starting conﬁguration, exploration of the surface of the
protease and waiting for the ﬂaps to open is common for
all the simulations. In Fig. 6 we show the behavior of the
substrate and the ﬂaps derived from other sample LD
simulations (see Table 1, Nos. 6 and 7). Fig. 6 (top) shows
that in the ﬁrst 500 ns of the simulation, the ﬂaps open a few
times but the substrate is not in a good position to enter the
binding site. It binds at;800 ns at a subsequent ﬂap opening
event, stabilizing the ﬂuctuations of the ﬂaps. A similar
simulation but with a different initial position of the substrate
leads to faster binding after 340 ns (Fig. 6, bottom). Multiple
short opening events can be seen before a longer one, which
leads to docking. Flap opening time is longer than in a sim-
ulation of the unbound protease due to the interaction of the
enzyme with the substrate. The ﬂuctuations of the ﬂap tips
are smaller after the binding.
The gain in energy upon binding is between 20 and 60
kcal/mol, depending on the value of R. However, it is quite
difﬁcult to compare this value with experimental binding free
energies (34), because the entropic part is not included in our
calculation. This would be difﬁcult to estimate because the
phase space of the unbound substrate is not properly
sampled, and it is likely to be large, considering possible
conformations of the unbound substrate. However, rough
estimate of the binding enthalpy can be made considering the
number of hydrogen bond contacts between the substrate and
the protease. Their number is either 16 or 24 if one also
includes the water-mediated hydrogen bonds (32). There-
fore, considering an average binding energy of 3–4 kcal/
mole per each hydrogen bond, the binding energy we obtain
from the simulation is in the correct range. Moreover, in our
all-atom simulations of the docking of the XK-263 inhibitor,
the difference in mean interaction energy inside and outside
the protease is ;30–40 kcal/mole (24).
Another conclusion that can be derived from this set of
simulations is that the substrate needs to be on the proper
side of the enzyme to enter the binding cleft. Also, the events
of docking happen on a faster timescale in the NVT dynamics
than in LD. LD has the effect of damping the dynamics,
which was shown before in the ﬂap opening frequencies and
intervals (22).
INTERNAL FLUCTUATIONS OF THE COMPLEX
Residual ﬂuctuations
To obtain information on the displacement of individual
residues, we calculated the root mean-square ﬂuctuations











where Rti and R
t
ave are the instantaneous and time-averaged
coordinates of residue i (Ca bead in our case), respectively,
and T is the number of trajectory frames. RMSF gives a
measure of the ﬂuctuations about the time-averaged struc-
ture. RMSF for the free and substrate bound protease are
reported in Fig. 7 (Table 1, Nos. 1 and 2) and compared to
the experimental temperature factors B of the 1HHP native
structure according to the relation RMSF2i ¼ 3Bi=8p2. The
parts that move the most in both structures are the ﬂaps and
the 17- and 39-turns or the so-called ear-cheek region (11).
The ﬂuctuations of the native protease compare well with the
experiment except for the ﬂap region because the ﬂap
opening is probably hindered in the crystal. A previous
Gaussian network model study (43) showed smaller ﬂuctu-
ations of the ﬂaps than we achieved, which is more in accord
with that found by experiment in a crystal. However, our aim
was to account for higher mobility of the ﬂap region to
simulate their full opening, allowing for substrate capture by
the native enzyme. In the simulation with the docked sub-
strate, the agreement is consistently very good, because in
the complexed HIV-1 PR, the ﬂaps do not open. A similar
pattern of RMSF is obtained from the simulation of the free
protease when the open conformations are excluded from the
RMSF calculation (22). Stabilization of ﬂaps upon formation
of the HIV-1 PR:substrate complex was also determined in
earlier all-atom MD simulation (10) and its principal compo-
nents analysis (44).
The ﬂuctuations of the substrate (green line) are asym-
metric because the N-terminal lysine is more mobile than
the C-terminal methionine. It has been shown by NMR
FIGURE 5 Density showing the areas explored by the
substrate while encountering the protease from various
starting positions between 80 and 100 A˚ from the surface
of the protease. (A) From the ﬂaps side (Table 1, No. 4). (B)
From the side of the protease (Table 1, No. 3). (C) from the
termini of the protease (Table 1, No. 5). HIV-1 PR is
shown in its starting conﬁguration with the ﬂaps closed
over the active site.
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experiments that an asymmetric ligand packs more tightly
with one of the ﬂaps (33). The density of the substrate within
the active site is also shown as an inset in Fig. 7. The three-
dimensional space occupied by the ﬂuctuating substrate is
indeed asymmetric at the extremities. The least ﬂuctuating
residue in the substrate is Glu at the P29 position (with
RMSF2i of 0.7 A˚
2). Other small ﬂuctuations below 1 A˚ are
for the residues of the cleaved bond (Leu and Ala). Even
though the extremities of the peptide are mobile, the cleaved
bond is stabilized within the active site cleft.
Dynamical correlations
The extent of the correlation between the residues may be
quantiﬁed by calculating a normalized covariance Cij be-
tween their ﬂuctuations
Cij ¼ Æðxi  ÆxiæÞðxj  ÆxjæÞæﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Æðxi  ÆxiæÞ2æÆðxj  ÆxjæÞ2æ
q ; (3)
where xi is a Cartesian coordinate of an atom and the brackets
represent the time averages over all conﬁgurations obtained
in the simulation. This so-called dynamical cross-correlation
matrix provides useful information about the relation of
motions of distant parts of the molecule. The value Cij varies
from1.0 to 1.0 for completely anticorrelated and correlated
motions, respectively. To compare the ﬂuctuations and their
directionality between the free and bound protease, we cal-
culated the correlation matrices for the unbound protease and
the one complexed with a nine-amino-acid substrate. Fig. 8
reports the dynamical correlation matrices evaluated from
MD trajectories (Table 1, Nos. 1 and 2) of the native protease
(left) and complexed with a substrate (right). The secondary
structure patterns are well conserved in both cases, as well as
FIGURE 6 Two sample substrate docking simulations.
Temperature (T), effective potential energy (E), distance
of the center of mass of the protease and the substrate
(dPr–subs), and ﬂap tip distances (dinter–tip) are reported.
FIGURE 7 Comparison of the experimental ﬂuctuations of the native
1HHP protease with RMSF2 derived from simulations of the free HIV-1 PR
and the complex with a peptide substrate. (Inset) Substrate density in the
HIV-1 PR:substrate complex showing the asymmetric ﬂuctuations of the
termini.
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the interface contacts, which remain positively correlated. In
the native protease matrix, spots of negative correlations are
clearly visible in the intermonomer quadrant in the region of
ﬂap contacts (i.e., around residues 50 and 150). These reﬂect
the counterphase movements of the ﬂaps that move away
from each other and from other regions of the opposite
monomer as they open. In the simulation with the docked
substrate the ﬂaps do not open and, conversely, the substrate
stabilizes the contact between the ﬂap tips. Consequently, the
negative correlation regions are generally decreased and in
particular the interﬂap tip region is turned into a positive
correlation region. The positive correlation between the sub-
strate and the ﬂap tips conﬁrms that the substrate stabilizes
the ﬂaps. Furthermore, the substrate motion is positively
correlated with the motion of the active site (residues 24–28),
which reﬂects the fact that the substrate must stay in contact
with the active site for the enzymatic reaction to take place.
These features are in agreement with those observed in
the all-atom MD simulations (15,16) and with an extended
Gaussian network model (45). As we previously reported,
the ﬂexibility of the region enclosed by the 17- and 39-turns
is essential for the ﬂaps to open because a simulation where
this site is artiﬁcially kept rigid does not show ﬂap opening
(21). This can explain the residual ﬂexibility of these sites
(small residual blue regions in the correlation matrix of the
complex).
Principal components analysis
We performed principal components analysis based on the
MD simulations of the complex (Table 1, No. 2) and pro-
jected the trajectory on the principal directions. The modes
with the highest amplitudes include the side movement and
contraction of the 17- and 39-turns. During the side move-
ment we observe closing of residues 45–48 over the sub-
strate, which is pushed toward the catalytic aspartates 25 and
125. In one of the modes we see the contraction of the 17-
and 39-turns whose movements were found to be correlated
with the ﬂap opening (11,21,22,46) but the ﬂaps do not open
because the substrate is present. In the 10 modes with the
highest eigenvalues, the substrate termini are mobile but the
central part less so. The ﬂap tip region is immobilized by the
interaction with the substrate. Fig. 9 shows two of the
principal modes from the simulation with a bound substrate.
One of the modes also shows bending of the monomers
around the C2V symmetry axis.
CONCLUSIONS
In this article, we extended our previously developed coarse-
grained model for HIV-1 PR to include the protease-
substrate interactions and applied it to the simulation of the
substrate capture and product release processes. The ex-
tremely reduced cost of the model has allowed us to perform
FIGURE 8 Dynamical correlation matrices evaluated
for the unbound protease (left) and for the complexed
protease (right). Residues of the two monomers and the
substrate are numbered subsequently and separated by
black lines. Color levels: blue [1,0.2]; cyan [0.2,0];
green [0,0.2]; yellow [0.2,0.7]; and red [0.7,1].
FIGURE 9 Two principal directions of motions (denoted in black)
derived from the simulations of the dynamics of the protease-substrate
complex showing the side movement (A) and contraction of the turns (B).
The 17- and 39-turns are shown in orange.
HIV-1 Protease Substrate Binding 4185
Biophysical Journal 92(12) 4179–4187
a large number of simulations of the substrate encounter and
its ﬁnal incorporation in the binding site and product release
after cleavage. This enabled us to detect the mechanism of
protease-substrate association. The substrate may approach
the protease from various sides and wanders around the
enzyme until it reaches the neighborhood of the binding site.
Then a complex interplay between the ﬂaps and the substrate
occurs; the interaction with the substrate modiﬁes the ﬂap
dynamics, making the opening more frequent and more
stable. The capture occurs when the ﬂaps are open and the
substrate is properly oriented with respect to the active site.
After the substrate entry, the ﬂaps do not close symmetri-
cally, but as one following the other. When the substrate is in
the active site, the closed conformation is stabilized, as
expected, at least until the substrate is cleaved. The structure
of the complex accurately reproduces the crystallographic
data and the interaction of the substrate with the ﬂaps sta-
bilizes the latter. Introduction of the appropriate bond cleav-
age results in the release of the products from the binding site
without opening of the ﬂaps. The products slide out on both
sides and after some time diffuse away from the protease.
The presence of the substrate suppresses ﬂap ﬂuctuations
but does not decrease the ﬂuctuations of the 17- and 39-turns,
which are believed to facilitate the ﬂap opening. The motions
of the substrate are positively correlated with the active site
residues, as well as with the ﬂap tips.
In conclusion, within a framework of the coarse-grained
model, we have analyzed the main features of the substrate
encounter and its dynamics in the active site of HIV-1 PR.
Our results suggest that the presence of the substrate modiﬁes
the protease internal mobility in ways that favor the capture.
SUPPLEMENTARY MATERIAL
A sample movie of the substrate encounter and accommo-
dation in the binding site of HIV-1 PR is available online as
Supplemental Material, and can be found by visiting BJ
Online at http://www.biophysj.org.
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